December 13, 2016
It seems like a war sometimes for those battling pleural mesothelioma. One of the most stubborn and aggressive types of cancer, researchers report that only 1 in 10 patients survive more than five years after diagnosis. Patients and their loved ones often have no choice but to seek physical and emotional comfort instead of controversial and invasive treatments.
There was a glimmer of hope in a recent study by Italian doctors who took a closer look at a small group of patients who responded well to a radical medical treatment known as extrapleural pneumonectomy (EPP). In an EPP procedure, surgeons remove parts of the lung, diaphragm, and the linings of the chest and heart.
This major surgical procedure is not for everyone – more than 75 percent of patients had a survival rate of less than 10 months following an EPP. But the Italian researchers noted that 23 percent of patients reported survival rates of no less than three years, and they set out to learn more about this group of survivors.
According to the study published in The Annals of Thoracic Surgery, those who benefitted from EPP were younger than average and had a form of mesothelioma that targets epithelioid cells (the most common form of mesothelioma) with limited involvement of lymph nodes. Finally, the group tended to have no known link to industries and materials where exposure to asbestos is common, such as mining, construction, heavy industry and the maritime sector.
There’s no silver bullet here, and treatment for those fighting mesothelioma remains somewhat controversial. But the latest findings mark a rare degree of progress in the stubborn fight against mesothelioma, which has no known late-stage cure.
“The optimal surgical approach is still a matter of debate,” said Giovanni Leuzzi, MD, from Regina Elena National Cancer Institute in Rome, Italy, who led the study. “Our study found clinico-surgical factors that can indicate which patients will benefit the most from surgery so that patients and their physicians can better decide the optimal course of therapy.”
The results of the scientists’ study have been published in The Annals of Thoracic Surgery.
Our Results
Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.
Confidential settlement for the wife of a Rhode Island man who died of mesothelioma cancer after exposure to window glazing compound contaminated with asbestos.
That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus Paul & Siegel has what it takes to fight against big corporate interests and win. That’s why we’ve recovered more than $1.3 billion for clients like you.
